Physician profile
Tim Conlan
NPI 1255329074
$1,121.56
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $577 · 2020: $71.08 · 2021: $52.81 · 2022: $269 · 2023: $122 · 2024: $29.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $519.04 | 2019-2022 | |
| Stryker Corporation | $149.50 | 2022-2023 | Mako |
| Zimmer Biomet Holdings, INC. | $142.27 | 2022-2023 | Rosa |
| Pacira Therapeutics, INC. | $112.52 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $43.22 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $36.37 | 2019-2023 | |
| Ferring Pharmaceuticals INC. | $29.57 | 2024 | Euflexxa |
| Bioventus LLC | $19.89 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.34 | 2023 | Exparel, Iovera, Zilretta |
| Baudax Bio INC. | $14.40 | 2021 | |
| Conmed Corporation | $13.20 | 2022 | |
| Medline Industries Lp | $12.63 | 2019 | |
| Fidia Pharma USA INC. | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Conlan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.